An official website of the United States government
Home
Name
Bryostatin 1
Alternate Names
Bryostatin
Abbreviations
BRYO
Category
Chemotherapy
Subcategory
Protein Kinase C Inhibitor
NSC Number
None
Primary Site
None
Histology
None
Remarks
Bryostatin1 is being studied in the tretment of cancer and certain brain conditions such as Alzheimer disease and stroke. It is currently in numerous clinical trials for: Leukemia, lymphoma, MDS, colorectal, ovarian, kidney, melanoma, breast, gastric, GE and pancreas malignancies. Code as "Other" treatment until FDA approval is received.
Coding
This drug should be coded
